Copyright
©The Author(s) 2015.
World J Hepatol. Feb 27, 2015; 7(2): 139-149
Published online Feb 27, 2015. doi: 10.4254/wjh.v7.i2.139
Published online Feb 27, 2015. doi: 10.4254/wjh.v7.i2.139
Ref. | Year | n | Comparator | Cut-off-level | Sensitivity | Specificity | AUC |
Marrero et al[20] | 2009 | 836 total (419 HCC) | Liver cirrhosis | 20 ng/mL | 59% | 90% | 0.8 |
Mao et al[21] | 2010 | 4217 total (789 HCC) | Amongst others healthy controls, HBV carriers, liver cirrhosis | 35 ng/mL | 58.20% | 85.30% | |
Farinati et al[22] | 2006 | 1158 HCC | No control | 400 ng/mL | 18% | 0.59 | |
Lok et al[23] | 2010 | 39 HCC, 77 matched controls | Hepatitis C | 20 ng/mL | 61% | 81% | 0.79 |
- Citation: Schütte K, Schulz C, Link A, Malfertheiner P. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis. World J Hepatol 2015; 7(2): 139-149
- URL: https://www.wjgnet.com/1948-5182/full/v7/i2/139.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i2.139